Östen Jonsson
Impact in
-
- Drug Transport and Resistance Mechanisms
- Cancer Treatment and Pharmacology
-
- Pharmacological Effects and Toxicity Studies
Papers in
- Oncology 5
- Drug Transport and Resistance Mechanisms 3
- Cancer Treatment and Pharmacology 2
- HER2/EGFR in Cancer Research 1
-
- Cancer therapeutics and mechanisms 1
- Co-authors
- Kjell Grankvist (7 shared papers)Roger Henriksson (7 shared papers)Parviz Behnam‐Motlagh (2 shared papers)Per‐Erik Sandström (1 shared paper)J. Denekamp (1 shared paper)Anders Widmark (1 shared paper)Karl Gunnar Engström (1 shared paper)Leif Bjermer (1 shared paper)
In The Last Decade
Östen Jonsson
7 papers receiving 100 citations
Peers
Comparison fields: 5 of 49
- Oncology 42
- Pediatrics, Perinatology and Child Health 17
- Pharmacology 7
- Radiology, Nuclear Medicine and Imaging 15
- Cardiology and Cardiovascular Medicine 14
Countries citing papers authored by Östen Jonsson
This map shows the geographic impact of Östen Jonsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Östen Jonsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Östen Jonsson more than expected).
Fields of papers citing papers by Östen Jonsson
This network shows the impact of papers produced by Östen Jonsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Östen Jonsson. The network helps show where Östen Jonsson may publish in the future.
Co-authors
The 10 scholars most cited alongside Östen Jonsson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 51 | |
| 2 | 1994 | 26 | |
| 3 | 1992 | 7 | |
| 4 | 1997 | 7 | |
| 5 | 1999 | 4 | |
| 6 | 1993 | 4 | |
| 7 | 1990 | 2 | |
| 8 | Access to public information in government agencies and archives : new e-services for archives: results from user and expert survey | 2011 | 0 |
About Östen Jonsson
Östen Jonsson is a scholar working on Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging, Biophysics and Surgery, having authored 8 papers that have together received 101 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (3 papers), Cancer Treatment and Pharmacology (2 papers), Electron Spin Resonance Studies (2 papers), Pharmacological Effects and Toxicity Studies (1 paper), Cancer therapeutics and mechanisms (1 paper), Antibiotics Pharmacokinetics and Efficacy (1 paper), Ultrasound and Hyperthermia Applications (1 paper) and HER2/EGFR in Cancer Research (1 paper). The work is most often cited by research in Oncology (42 citations), Pediatrics, Perinatology and Child Health (17 citations), Pharmacology (7 citations), Radiology, Nuclear Medicine and Imaging (15 citations) and Cardiology and Cardiovascular Medicine (14 citations). Östen Jonsson has collaborated with scholars based in Sweden and Norway. Frequent co-authors include Kjell Grankvist, Roger Henriksson, Parviz Behnam‐Motlagh, Per‐Erik Sandström, J. Denekamp, Anders Widmark, Karl Gunnar Engström, Leif Bjermer, Jan‐Erik Damber and Per Bergström. Their work appears in journals such as European Journal of Cancer, British Journal of Cancer, The Prostate, Biochemical Pharmacology and International Journal of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.